Modulation of P450-dependent ifosfamide pharmacokinetics: a better understanding of drug activation in vivo
1998

Understanding Ifosfamide Metabolism

Sample size: 10 publication Evidence: moderate

Author Information

Author(s): EGC Brain, LJ Yu, K Gustafsson, P Drewes, DJ Waxman

Primary Institution: Boston University

Hypothesis

Can the balance between drug activation and inactivation of ifosfamide be modulated using P450 inducers and inhibitors?

Conclusion

The study demonstrates that specific P450 inducers and inhibitors can significantly alter the metabolism of ifosfamide, potentially improving its therapeutic use.

Supporting Evidence

  • Induction of liver P450 2B enzymes significantly decreased the fraction of ifosfamide undergoing activation.
  • Using metyrapone increased the total fraction of ifosfamide metabolized via the activation pathway.
  • Dexamethasone treatment resulted in increased peak plasma concentrations of ifosfamide metabolites.

Takeaway

Ifosfamide is a cancer drug that can be changed in how it works by using other drugs that affect how it's processed in the body.

Methodology

The study used adult male Fischer 344 rats to investigate the effects of various P450 inducers and inhibitors on ifosfamide metabolism.

Limitations

The study was conducted in rats, which may not fully represent human metabolism.

Participant Demographics

Adult male Fischer 344 rats, aged 7-11 weeks.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication